• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The metabolic clearance rate, serum half-time and apparent distribution space of authentic biosynthetic human growth hormone in growth hormone-deficient patients.

作者信息

Jørgensen J O, Flyvbjerg A, Christiansen J S

机构信息

Second University Clinic of Internal Medicine, Aarhus Kommunehospital, Denmark.

出版信息

Acta Endocrinol (Copenh). 1989 Jan;120(1):8-13. doi: 10.1530/acta.0.1200008.

DOI:10.1530/acta.0.1200008
PMID:2911943
Abstract

We studied the metabolic clearance rate (MCR) serum half-time (t1/2) and apparent distribution space (DS) of unlabelled, authentic, biosynthetic human growth hormone (B-hGH) in 9 GH-deficient patients by means of the constant iv infusion to equilibrium technique. B-hGH was infused for 3 h at a rate of 33 ng.kg-1.min-1 after which the disappearance from serum of GH was followed for 1 h. The mean +/- SEM values for MCR, t1/2 and DS were: 2.3 +/- 0.6 ml.kg-1.min-1, 21.1 +/- 1.7 min and 67.6 +/- 14.6 ml/kg, respectively. The disappearance of GH was monoexponential for the first 30 min, during which 75% of the GH had been cleared. The disappearance rate during the last 30 min of the observation period was somewhat lower, still approximately 90% of the GH had been eliminated after 60 min.

摘要

相似文献

1
The metabolic clearance rate, serum half-time and apparent distribution space of authentic biosynthetic human growth hormone in growth hormone-deficient patients.
Acta Endocrinol (Copenh). 1989 Jan;120(1):8-13. doi: 10.1530/acta.0.1200008.
2
Renal clearance, metabolic clearance rate, and half-life of human growth hormone in young and aged subjects.青年和老年受试者中人生长激素的肾清除率、代谢清除率及半衰期
J Clin Endocrinol Metab. 1992 Dec;75(6):1487-90. doi: 10.1210/jcem.75.6.1464653.
3
Assessment of growth hormone (GH) plasma clearance rate, half-life, and volume of distribution in acromegalic patients: the combined GH-octreotide infusion.
J Clin Endocrinol Metab. 1995 Nov;80(11):3279-83. doi: 10.1210/jcem.80.11.7593438.
4
Diurnal variation in the elimination rate of human growth hormone (GH): the half-life of serum GH is prolonged in the evening, and affected by the source of the hormone, as well as by body size and serum estradiol.
J Clin Endocrinol Metab. 1993 Jul;77(1):216-20. doi: 10.1210/jcem.77.1.8325945.
5
Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.健康和慢性肾衰竭患者中重组人生长激素的代谢清除率
J Clin Invest. 1994 Mar;93(3):1163-71. doi: 10.1172/JCI117069.
6
Time mode of growth hormone (GH) entry into the bloodstream and steady-state plasma GH concentrations, rather than sex, estradiol, or menstrual cycle stage, primarily determine the GH elimination rate in healthy young women and men.
J Clin Endocrinol Metab. 1999 Aug;84(8):2862-9. doi: 10.1210/jcem.84.8.5881.
7
Prolactin and growth hormone clearance in neonatal boars.
J Anim Sci. 1993 Aug;71(8):2055-60. doi: 10.2527/1993.7182055x.
8
Metabolic clearance rate of biosynthetic growth hormone after endogenous growth hormone suppression with a somatostatin analogue in chronic renal failure patients and control subjects.慢性肾衰竭患者和对照受试者使用生长抑素类似物抑制内源性生长激素后生物合成生长激素的代谢清除率。
Clin Endocrinol (Oxf). 1993 Sep;39(3):337-43. doi: 10.1111/j.1365-2265.1993.tb02374.x.
9
Half-life of exogenous growth hormone following suppression of endogenous growth hormone secretion with somatostatin in type I (insulin-dependent) diabetes mellitus.在I型(胰岛素依赖型)糖尿病患者中,使用生长抑素抑制内源性生长激素分泌后外源性生长激素的半衰期。
Clin Endocrinol (Oxf). 1992 Mar;36(3):255-63. doi: 10.1111/j.1365-2265.1992.tb01441.x.
10
The half-life of exogenous growth hormone after suppression of endogenous growth hormone secretion with somatostatin.
Clin Endocrinol (Oxf). 1989 Apr;30(4):443-50. doi: 10.1111/j.1365-2265.1989.tb00444.x.